Real-time enrollment status for this kidney cancer clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 11:27 PM UTC
| NCT Number | NCT05327686 |
| Recruiting Status | Recruiting |
| Condition | Kidney Cancer |
| Phase | PHASE2 |
| Target Enrollment | 240 participants |
| Active Locations | 323 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 19, 2026: Clinical trial NCT05327686 is currently recruiting participants. This phase2 study for kidney cancer is actively seeking new participants at 323 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05327686 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 323 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05327686 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.